Heethox-K, a recently established company, represents a new era of innovation and expertise in the healthcare industry. Founded by a dynamic team of experts, all with extensive exposure to renowned organizations and multinational companies, Heethox-K embodies a commitment to addressing critical healthcare challenges in India.
Leverage our world-class facilities and seasoned experts to develop tailor-made antibodies. With precision at our core, we ensure specific, high-affinity antibodies that suit your research and diagnostic requirements.
Our dedicated team pioneers in crafting accurate, reliable, and reproducible assays. With our meticulous design and optimization process, we ensure your assays deliver consistent and dependable results every time.
Delve deep into the world of gene expression with our advanced transcriptome profiling services. Discover the intricacies of cellular responses and harness this knowledge to drive your research forward.
At Heethox-K, we recognize the importance of precision in diagnostics. Our bespoke diagnostic kits are designed to provide rapid, accurate, and actionable insights, playing a pivotal role in timely medical interventions.
In today’s fast-paced world, quick results can be a game-changer. Our rapid test cassettes are not only swift but also remarkably accurate, ensuring you get the reliable information you need, when you need it.
Groundbreaking discoveries deserve rigorous testing. Our comprehensive clinical trial and validation services ensure that your products meet the highest standards of efficacy, safety, and reliability.
1. Proud recipient of the Pfizer 2025 Grant from Pfizer, recognizing our innovation and potential to deliver transformative healthcare solutions.
2. Proudly featured among the Top 50 Start-ups in India by NITI Aayog in the prestigious Coffee Table Book (6th Edition, 2024), highlighting our contribution to India’s innovation ecosystem.
3. Recipient of the highly competitive NIDHI-PRAYAS Grant from Department of Science and Technology (DST), supporting early-stage technological innovation and product development.
4. Shortlisted for the SBIRI Grant by Biotechnology Industry Research Assistance Council (BIRAC), recognizing the translational potential of our breakthrough diagnostic platform (site visit pending).
5. Awarded the prestigious AMRIT Grant by Indian Council of Medical Research (ICMR) for advancing affordable and accessible healthcare solutions.
6. Ranked among the Top 10 Start-ups at the Innov8 Start-up Competition during Asia Health 2024, showcasing our innovation on an international stage.
At ICSCD 2024, Chandrapur, Maharashtra, acknowledging the novelty and clinical relevance of our diagnostic innovation.
Our Combo Sickle Cell Disease Rapid Test Card Prototype received significant acclaim at Heamatocon 2023, underscoring its potential to transform haematology diagnostics.
82, 2nd Floor, RC Block,
Vydehi Hospital Campus,
EPIP Zone, Whitefield,
Bengaluru,
Karnataka 560066.
At ICSCD 2024, Chandrapur, Maharashtra, acknowledging the novelty and clinical relevance of our diagnostic innovation.
Our Combo Sickle Cell Disease Rapid Test Card Prototype received significant acclaim at Heamatocon 2023, underscoring its potential to transform haematology diagnostics.
82, 2nd Floor, RC Block,
Vydehi Hospital Campus,
EPIP Zone, Whitefield,
Bengaluru,
Karnataka 560066.
Office address:
604, 6th Floor, GD-ITL Tower/B08,
Netaji Subhash Place,
New Delhi – 110034
Factory Address:
Plot no. 50 NR,
B wing Ground floor rapid department,
Jambusar Road,
Aman Engineering Mahuvad,
Padra, Vadodara,
Gujarat -391440.
Copyright © 2026 Heethox-K. All Rights Reserved. Website developed by Dalvkot Utility Enterprises Pvt Ltd